Bravecto Quantum’s active ingredient, fluralaner, is part of a class of antiparasitic drugs known as isoxazolines. Currently, several isoxazoline-based products are approved to treat and control fleas ...
FDA approves Bravecto Quantum (fluralaner), the first annual injection against fleas and ticks in dogs, offering 12 months of ...
Bravecto Quantum, a breakthrough, long-acting flea and tick treatment and preventative for dogs, will be available soon. Made by Merck Animal Health, the once-yearly shot can protect dogs for up to 12 ...
Dogs across the U.S. could soon get longer-lasting protection against pesky parasites thanks to a new treatment approved by federal regulators Thursday. NOTE: This video is from a previous report. The ...
(RTTNews) - Merck Animal Health, a division of Merck & Co., Inc. (MRK), announced the U.S. Food and Drug Administration approval of BRAVECTO QUANTUM (fluralaner for extended-release injectable ...
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback